Challenges and opportunities for hydrogen production from microalgae

Plant Biotechnology Journal

Volumn 14, Issue 7, 2016, Pages 1487-1499

  Oey, Melanie ^a   Sawyer, Anne Linda ^b   Ross, Ian Lawrence ^a   Hankamer, Ben ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

algae; fuel; hydrogen; renewable energy; solar; water

Indexed keywords

BIOFUEL; HYDROGEN; HYDROGENASE; OXYGEN;

BIOTECHNOLOGY; CHEMISTRY; ENERGY CONSERVATION; METABOLISM; MICROALGA; PHOTOBIOREACTOR; PHOTOLYSIS; PHYSIOLOGY; THEORETICAL MODEL; THYLAKOID; TRENDS;

BIOFUELS; BIOTECHNOLOGY; CONSERVATION OF ENERGY RESOURCES; HYDROGEN; HYDROGENASE; MICROALGAE; MODELS, THEORETICAL; OXYGEN; PHOTOBIOREACTORS; PHOTOLYSIS; THYLAKOIDS;

EID: 84975457788     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12516     Document Type: Review

References (57)

1. Berin, M.C. and Sampson, H.A. (2013) Mucosal immunology of food allergy. Curr. Biol. 23, R389–R400.
2. Bogh, K.L., Nielsen, H., Madsen, C.B., Mills, E.N., Rigby, N., Eiwegger, T., Szepfalusi, Z. et al. (2012) IgE epitopes of intact and digested Ara h 1: a comparative study in humans and rats. Mol. Immunol. 51, 337–346.
3. Bogh, K.L., Nielsen, H., Eiwegger, T., Madsen, C.B., Mills, E.N., Rigby, N.M., Szepfalusi, Z. et al. (2014) IgE versus IgG4 epitopes of the peanut allergen Ara h 1 in patients with severe allergy. Mol. Immunol. 58, 169–176.
4. Boynton, J.E., Gillham, N.W., Harris, E.H., Hosler, J.P., Johnson, A.M., Jones, A.R., Randolph-Anderson, B.L. et al. (1988) Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science, 240, 1534– 1538.
5. Burks, A.W., Shin, D., Cockrell, G., Stanley, J.S., Helm, R.M. and Bannon, G.A. (1997) Mapping and mutational analysis of the IgE-binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity. Eur. J. Biochem. 245, 334–339.
6. Burton, O.T., Logsdon, S.L., Zhou, J.S., Medina-Tamayo, J., Abdel-Gadir, A., Noval Rivas, M., Koleoglou, K.J. et al. (2014) Oral immunotherapy induces IgG antibodies that act through FcgammaRIIb to suppress IgE-mediated hypersensitivity. J. Allergy Clin. Immunol. 134, 1310–1317. e1316.
7. Chruszcz, M., Maleki, S.J., Majorek, K.A., Demas, M., Bublin, M., Solberg, R., Hurlburt, B.K. et al. (2011) Structural and immunologic characterization of Ara h 1, a major peanut allergen. J. Biol. Chem. 286, 39318–39327.
8. Codreanu, F., Collignon, O., Roitel, O., Thouvenot, B., Sauvage, C., Vilain, A.C., Cousin, M.O. et al. (2011) A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis. Int. Arch. Allergy Immunol. 154, 216–226.
9. Dreesen, I.A., Charpin-El Hamri, G. and Fussenegger, M. (2010) Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection. J. Biotechnol. 145, 273–280.
10. Flinterman, A.E., Knol, E.F., Lencer, D.A., Bardina, L., den Hartog Jager, C.F., Lin, J., Pasmans, S.G. et al. (2008) Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J. Allergy Clin. Immunol. 121, 737–743. e710.
11. Flinterman, A.E., Pasmans, S.G., den Hartog Jager, C.F., Hoekstra, M.O., Bruijnzeel-Koomen, C.A., Knol, E.F. and van Hoffen, E. (2010) T cell responses to major peanut allergens in children with and without peanut allergy. Clin. Exp. Allergy, 40, 590–597.
12. Franklin, S., Ngo, B., Efuet, E. and Mayfield, S.P. (2002) Development of a GFP reporter gene for Chlamydomonas reinhardtii chloroplast. Plant J. 30, 733– 744.
13. Gregory, J.A., Li, F., Tomosada, L.M., Cox, C.J., Topol, A.B., Vinetz, J.M. and Mayfield, S. (2012) Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission. PLoS ONE, 7, e37179.
14. Gregory, J.A., Topol, A.B., Doerner, D.Z. and Mayfield, S. (2013) Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines. Appl. Environ. Microbiol. 79, 3917–3925.
15. Hebling, C.M., McFarland, M.A., Callahan, J.H. and Ross, M.M. (2013) Global proteomic screening of protein allergens and advanced glycation endproducts in thermally processed peanuts. J. Agric. Food Chem. 61, 5638–5648.
16. Hurlburt, B.K., McBride, J.K., Nesbit, J.B., Ruan, S. and Maleki, S.J. (2014) Purification of recombinant peanut Allergen Ara h 1 and comparison of IgE binding to the natural protein. Foods, 3, 642–657.
17. Krebitz, M., Wiedermann, U., Essl, D., Steinkellner, H., Wagner, B., Turpen, T.H., Ebner, C. et al. (2000) Rapid production of the major birch pollen allergen Bet v 1 in Nicotiana benthamiana plants and its immunological in vitro and in vivo characterization. FASEB J. 14, 1279–1288.
18. Krebitz, M., Wagner, B., Ferreira, F., Peterbauer, C., Campillo, N., Witty, M., Kolarich, D. et al. (2003) Plant-based heterologous expression of Mal d 2, a thaumatin-like protein and allergen of apple (Malus domestica), and its characterization as an antifungal protein. J. Mol. Biol. 329, 721–730.
19. Kucuk, Z.Y., Strait, R., Khodoun, M.V., Mahler, A., Hogan, S. and Finkelman, F.D. (2012) Induction and suppression of allergic diarrhea and systemic anaphylaxis in a murine model of food allergy. J. Allergy Clin. Immunol. 129, 1343–1348.
20. Lehtimaki, N., Koskela, M.M. and Mulo, P. (2015) Posttranslational modifications of chloroplast proteins: an emerging field. Plant Physiol. 168, 768–775.
21. Leonard, S.A., Martos, G., Wang, W., Nowak-Wegrzyn, A. and Berin, M.C. (2012) Oral immunotherapy induces local protective mechanisms in the gastrointestinal mucosa. J. Allergy Clin. Immunol. 129, 1579–1587. e1571.
22. Li, X.M., Srivastava, K., Grishin, A., Huang, C.K., Schofield, B., Burks, W. and Sampson, H.A. (2003a) Persistent protective effect of heat-killed Escherichia coli producing “engineered”, recombinant peanut proteins in a murine model of peanut allergy. J. Allergy Clin. Immunol. 112, 159–167.
23. Li, X.M., Srivastava, K., Huleatt, J.W., Bottomly, K., Burks, A.W. and Sampson, H.A. (2003b) Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J. Immunol. 170, 3289–3295.
24. Lin, J., Bruni, F.M., Fu, Z., Maloney, J., Bardina, L., Boner, A.L., Gimenez, G. et al. (2012) A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay. J. Allergy Clin. Immunol. 129, 1321–1328. e1325.
25. MacGlashan, D. Jr. (2008) IgE receptor and signal transduction in mast cells and basophils. Curr. Opin. Immunol. 20, 717–723.
26. Matsuoka, T., Shamji, M.H. and Durham, S.R. (2013) Allergen immunotherapy and tolerance. Allergol. Int. 62, 403–413.
27. Mayfield, S.P., Franklin, S.E. and Lerner, R.A. (2003) Expression and assembly of a fully active antibody in algae. Proc. Natl Acad. Sci. USA, 100, 438–442.
28. Mondoulet, L., Dioszeghy, V., Puteaux, E., Ligouis, M., Dhelft, V., Plaquet, C., Dupont, C. et al. (2015) Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model. J. Allergy Clin. Immunol. 135, 1546–1557.
29. Mueller, G.A., Maleki, S.J., Johnson, K., Hurlburt, B.K., Cheng, H., Ruan, S., Nesbit, J.B. et al. (2013) Identification of Maillard reaction products on peanut allergens that influence binding to the receptor for advanced glycation end products. Allergy, 68, 1546–1554.
30. Nelson, H.S., Lahr, J., Rule, R., Bock, A. and Leung, D. (1997) Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J. Allergy Clin. Immunol. 99, 744–751.
31. Neutra, M.R. and Kozlowski, P.A. (2006) Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6, 148–158.
32. Noor-Mohammadi, S., Pourmir, A. and Johannes, T.W. (2012) Method to assemble and integrate biochemical pathways into the chloroplast genome of Chlamydomonas reinhardtii. Biotechnol. Bioeng. 109, 2896–2903.
33. Ogo, Y., Takahashi, H., Wang, S. and Takaiwa, F. (2014) Generation mechanism of novel, huge protein bodies containing wild type or hypoallergenic derivatives of birch pollen allergen Bet v 1 in rice endosperm. Plant Mol. Biol. 86, 111–123.
34. Panel, N.I.-S.E., Boyce, J.A., Assa’ad, A., Burks, A.W., Jones, S.M., Sampson, H.A., Wood, R.A. et al. (2010) Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J. Allergy Clin. Immunol. 126, S1–S58.
35. Perovic, I., Milovanovic, M., Stanic, D., Burazer, L., Petrovic, D., Milcic-Matic, N., Gafvelin, G. et al. (2009) Allergenicity and immunogenicity of the major mugwort pollen allergen Art v 1 chemically modified by acetylation. Clin. Exp. Allergy, 39, 435–446.
36. Puigbo, P., Bravo, I.G. and Garcia-Vallve, S. (2008) E-CAI: a novel server to estimate an expected value of Codon Adaptation Index (eCAI). BMC Bioinformatics, 9, 65.
37. Rasala, B.A., Muto, M., Lee, P.A., Jager, M., Cardoso, R.M., Behnke, C.A., Kirk, P. et al. (2010) Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol. J. 8, 719–733.
38. Reber, L.L., Marichal, T., Mukai, K., Kita, Y., Tokuoka, S.M., Roers, A., Hartmann, K. et al. (2013) Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice. J. Allergy Clin. Immunol. 132, 881–888.
39. Ren, C., Zhang, Q., Wang, G., Ai, C., Hu, M., Liu, X., Tian, F. et al. (2014) Modulation of peanut-induced allergic immune responses by oral lactic acid bacteria-based vaccines in mice. Appl. Microbiol. Biotechnol. 98, 6353–6364.
40. Sampson, H.A. (2013) Peanut oral immunotherapy: is it ready for clinical practice?. J. Allergy Clin. Immunol. Pract. 1, 15–21.
41. Schmidt, G., Gadermaier, G., Pertl, H., Siegert, M., Oksman-Caldentey, K.M., Ritala, A., Himly, M. et al. (2008) Production of recombinant allergens in plants. Phytochem. Rev. 7, 539–552.
42. Siegert, M., Pertl-Obermeyer, H., Gadermaier, G., Ferreira, F. and Obermeyer, G. (2012) Expression of the major mugwort pollen allergen Art v 1 in tobacco plants and cell cultures: problems and perspectives for allergen production in plants. Plant Cell Rep. 31, 561–571.
43. Soares-Weiser, K., Takwoingi, Y., Panesar, S.S., Muraro, A., Werfel, T., Hoffmann-Sommergruber, K., Roberts, G. et al. (2014) The diagnosis of food allergy: a systematic review and meta-analysis. Allergy, 69, 76–86.
44. Stanley, J.S., King, N., Burks, A.W., Huang, S.K., Sampson, H., Cockrell, G., Helm, R.M. et al. (1997) Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch. Biochem. Biophys. 342, 244–253.
45. Sun, J., Arias, K., Alvarez, D., Fattouh, R., Walker, T., Goncharova, S., Kim, B. et al. (2007) Impact of CD40 ligand, B cells, and mast cells in peanut-induced anaphylactic responses. J. Immunol. 179, 6696–6703.
46. Surzycki, R., Greenham, K., Kitayama, K., Dibal, F., Wagner, R., Rochaix, J.D., Ajam, T. et al. (2009) Factors effecting expression of vaccines in microalgae. Biologicals, 37, 133–138.
47. Takagi, H., Hiroi, T., Yang, L., Tada, Y., Yuki, Y., Takamura, K., Ishimitsu, R. et al. (2005) A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc. Natl Acad. Sci. USA, 102, 17525–17530.
48. Tordesillas, L., Goswami, R., Benede, S., Grishina, G., Dunkin, D., Jarvinen, K.M., Maleki, S.J. et al. (2014) Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J. Clin. Invest. 124, 4965–4975.
49. Tran, M., Zhou, B., Pettersson, P.L., Gonzalez, M.J. and Mayfield, S.P. (2009) Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts. Biotechnol. Bioeng. 104, 663–673.
50. Uermosi, C., Beerli, R.R., Bauer, M., Manolova, V., Dietmeier, K., Buser, R.B., Kundig, T.M. et al. (2010) Mechanisms of allergen-specific desensitization. J. Allergy Clin. Immunol. 126, 375–383.
51. Uermosi, C., Zabel, F., Manolova, V., Bauer, M., Beerli, R.R., Senti, G., Kundig, T.M. et al. (2014) IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization. Allergy, 69, 338–347.
52. Vickery, B.P., Lin, J., Kulis, M., Fu, Z., Steele, P.H., Jones, S.M., Scurlock, A.M. et al. (2013) Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J. Allergy Clin. Immunol. 131, 128–134.
53. Vickery, B.P., Scurlock, A.M., Kulis, M., Steele, P.H., Kamilaris, J., Berglund, J.P., Burk, C. et al. (2014) Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J. Allergy Clin. Immunol. 133, 468–475.
54. Voehringer, D. (2013) Protective and pathological roles of mast cells and basophils. Nat. Rev. Immunol. 13, 362–375.
55. Wang, J. and Sampson, H.A. (2012) Treatments for food allergy: how close are we? Immunol. Res. 54, 83–94.
56. Wang, X., Su, J., Sherman, A., Rogers, G., Lia, G., Hoffman, B., Leong, K. et al. (2015) Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T-cells. Blood J. 125, 2418–2427.
57. Wood, R.A., Sicherer, S.H., Burks, A.W., Grishin, A., Henning, A.K., Lindblad, R., Stablein, D. et al. (2013) A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy, 68, 803–808.